vs

Side-by-side financial comparison of Bank of Marin Bancorp (BMRC) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $34.1M, roughly 1.2× Bank of Marin Bancorp). Bank of Marin Bancorp runs the higher net margin — 24.9% vs -17.2%, a 42.2% gap on every dollar of revenue. Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 23.3%).

American River Bank was a community bank founded in 1983 by Robert H. Daneke, who served as first president and CEO, and Bill L. Withrow, the first Chairman of the Board, and served the Greater Sacramento area in California. As of 2019, It operated ten branches in Northern CA. American River Bank which offered both business and personal financial services and was a wholly owned subsidiary of American River Bankshares.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BMRC vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.2× larger
STIM
$41.8M
$34.1M
BMRC
Higher net margin
BMRC
BMRC
42.2% more per $
BMRC
24.9%
-17.2%
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
23.3%
BMRC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BMRC
BMRC
STIM
STIM
Revenue
$34.1M
$41.8M
Net Profit
$8.5M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
24.9%
-17.2%
Revenue YoY
85.7%
Net Profit YoY
74.5%
43.2%
EPS (diluted)
$0.53
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMRC
BMRC
STIM
STIM
Q1 26
$34.1M
Q4 25
$27.0M
$41.8M
Q3 25
$30.9M
$37.3M
Q2 25
$10.3M
$38.1M
Q1 25
$27.8M
$32.0M
Q4 24
$22.2M
$22.5M
Q3 24
$27.2M
$18.5M
Q2 24
$22.5M
$16.4M
Net Profit
BMRC
BMRC
STIM
STIM
Q1 26
$8.5M
Q4 25
$-39.5M
$-7.2M
Q3 25
$7.5M
$-9.0M
Q2 25
$-8.5M
$-10.1M
Q1 25
$4.9M
$-12.7M
Q4 24
$6.0M
$-12.7M
Q3 24
$4.6M
$-13.3M
Q2 24
$-21.9M
$-9.8M
Gross Margin
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Operating Margin
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
-212.6%
-12.1%
Q3 25
31.1%
-19.6%
Q2 25
-108.8%
-21.1%
Q1 25
23.3%
-34.4%
Q4 24
43.5%
-51.0%
Q3 24
25.7%
-41.7%
Q2 24
-153.0%
-51.7%
Net Margin
BMRC
BMRC
STIM
STIM
Q1 26
24.9%
Q4 25
-146.5%
-17.2%
Q3 25
24.3%
-24.3%
Q2 25
-82.9%
-26.6%
Q1 25
17.5%
-39.6%
Q4 24
27.1%
-56.4%
Q3 24
16.8%
-72.0%
Q2 24
-97.5%
-59.8%
EPS (diluted)
BMRC
BMRC
STIM
STIM
Q1 26
$0.53
Q4 25
$-2.48
$-0.10
Q3 25
$0.47
$-0.13
Q2 25
$-0.53
$-0.15
Q1 25
$0.30
$-0.21
Q4 24
$0.38
$-0.34
Q3 24
$0.28
$-0.44
Q2 24
$-1.36
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMRC
BMRC
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$394.5M
$22.4M
Total Assets
$3.9B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Total Debt
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Stockholders' Equity
BMRC
BMRC
STIM
STIM
Q1 26
$394.5M
Q4 25
$394.7M
$22.4M
Q3 25
$443.8M
$27.4M
Q2 25
$438.5M
$27.1M
Q1 25
$439.6M
$35.5M
Q4 24
$435.4M
$27.7M
Q3 24
$437.0M
$9.4M
Q2 24
$434.9M
$19.4M
Total Assets
BMRC
BMRC
STIM
STIM
Q1 26
$3.9B
Q4 25
$3.9B
$141.6M
Q3 25
$3.9B
$145.5M
Q2 25
$3.7B
$134.7M
Q1 25
$3.8B
$142.0M
Q4 24
$3.7B
$140.9M
Q3 24
$3.8B
Q2 24
$3.7B
$96.8M
Debt / Equity
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMRC
BMRC
STIM
STIM
Operating Cash FlowLast quarter
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
$39.1M
$908.0K
Q3 25
$12.5M
$-785.0K
Q2 25
$8.0M
$-3.5M
Q1 25
$4.9M
$-17.0M
Q4 24
$28.4M
$-8.6M
Q3 24
$9.9M
$-5.4M
Q2 24
$3.4M
$-5.0M
Free Cash Flow
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
$37.3M
$692.0K
Q3 25
$12.1M
$-899.0K
Q2 25
$7.1M
$-3.8M
Q1 25
$4.6M
$-17.2M
Q4 24
$27.8M
$-8.7M
Q3 24
$9.8M
$-5.8M
Q2 24
$3.4M
$-5.6M
FCF Margin
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
138.1%
1.7%
Q3 25
39.0%
-2.4%
Q2 25
68.7%
-9.9%
Q1 25
16.6%
-53.8%
Q4 24
125.7%
-38.6%
Q3 24
36.0%
-31.3%
Q2 24
15.0%
-34.0%
Capex Intensity
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
6.7%
0.5%
Q3 25
1.3%
0.3%
Q2 25
9.4%
0.7%
Q1 25
1.1%
0.7%
Q4 24
2.3%
0.4%
Q3 24
0.4%
2.1%
Q2 24
0.4%
3.7%
Cash Conversion
BMRC
BMRC
STIM
STIM
Q1 26
Q4 25
Q3 25
1.66×
Q2 25
Q1 25
1.01×
Q4 24
4.73×
Q3 24
2.16×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMRC
BMRC

Net Interest Income$30.3M89%
Noninterest Income$3.8M11%

STIM
STIM

Segment breakdown not available.

Related Comparisons